Fingolimod Versus Teiflunomide- Characteristics Of Patients Diagnosed With Relapsing Remitting Multiple Sclerosis And Taking Oral Disease Modifying Therapies
May 1, 2016, 00:00
10.1016/j.jval.2016.03.224
https://www.valueinhealthjournal.com/article/S1098-3015(16)00292-8/fulltext
Title :
Fingolimod Versus Teiflunomide- Characteristics Of Patients Diagnosed With Relapsing Remitting Multiple Sclerosis And Taking Oral Disease Modifying Therapies
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)00292-8&doi=10.1016/j.jval.2016.03.224
First page :
A70
Section Title :
Neurological Disorders - Health Care Use & Policy Studies
Open access? :
No
Section Order :
1582